Are the Patients Having Pets at Greater Risk of Carrying Multidrug Resistance Bacteriae? (BRANITRANS)
Introduction : The multidrug resistance (MDR) Bacteriae are growing and are a public health problem. The known risk factors to be expanding of MDR Bacteriae are: taken antibiotics, hospitalization, journey in a country at risk. Other risk factors are emitted in hypothesis as the presence of pets.
Aim : The primary objective is to study the association between the presence of a pet and the presence of a MDR bacteria. Methods : Cross sectional study will be performed in Reims University hospital in internal medicine ward.
調査の概要
詳細な説明
Introduction : The multidrug resistance (MDR) Bacteriae are growing and are a public health problem. The known risk factors to be expanding of MDR Bacteriae are: taken antibiotics, hospitalization, journey in a country at risk. Other risk factors are emitted in hypothesis as the presence of pets.
Aim : The primary objective is to study the association between the presence of a pet and the presence of a MDR bacteria.
Methods : Cross sectional study will be performed in Reims University hospital in internal medicine ward. Within the framework of the management of patients in internal medicine ward, all the hospitalized patients have systematically a screening of MDR Bacteriae. A questionnaire will be put handed to all the patients during their hospitalization as soon as they will be able to answer it. They will be informed about the objectives of the study. If the patient agrees to participate in the study, the questionnaire will be filled by every patient. It includes essentially closed questions and some open questions. A descriptive analysis will be performed. Bivariate analysis will be performed to investigate the relation between the presence of a pet and the presence of a MDR bacteria and clinical variables Multivariate logistic regression will be performed to investigate the factors independently related to the presence of a MDR bacteria.
研究の種類
入学 (予想される)
連絡先と場所
研究連絡先
- 名前:Firouze BANI SADR
- 電話番号:33 3.26.78.71.86
- メール:fbanisadr@chu-reims.fr
研究場所
-
-
-
Reims、フランス、51092
- 募集
- CHU Reims
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Patients who were screened for MDR bacteria
- Patients who accepted to participate in the study
- >18yo
exclusion criteria :
- Patient hospitalized before admission in our ward and having acquired a MDR bacteria in the course of care.
- Patients coming from nursing home or institutionalized patients
- Patient who cannot communicated
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:ケースクロスオーバー
- 時間の展望:断面図
コホートと介入
グループ/コホート |
介入・治療 |
---|---|
Patients hospitalized in internal medicine ward
Patients included are patients hospitalized in internal medicine ward.
|
questionnaire will be filled by every patient
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
時間枠 |
---|---|
Association between the presence of a pet and the presence of a MDR bacteria
時間枠:Day0
|
Day0
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (予想される)
研究の完了 (予想される)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- PO17041
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。